Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011168 (
dysphagia
)
15,644
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We assessed the Quality of Life (QOL) of 116 patients with inoperable esophageal cancer who were mainly treated with radiotherapy between 1978 and 1993. Factors including
dysphagia
, weight loss, side effects of radiotherapy,P.S. and psychological status were assessed retrospectively.
Dysphagia
was assessed using a swallowing-function scoring system. Initial improvement in
dysphagia
occurred in 68% of the 71 assessable patients. Radiotherapy was also effective for the other symptoms, including swallowing pain, anterior chest pain and vomiting. Improvement rates were 73%, 60% and 82%, respectively. The major side effects were pain of the pharynx, general fatigue, epigastralgia and appetite loss. But most side effects resolved within 10 days after the end of radiotherapy. Improvement of
dysphagia
resulted in reduced weight loss of the patients. Average weight loss was about 3 kg/month before radiotherapy. This was reduced after radiotherapy to 0.78 kg/month in patients who had improvement of
dysphagia
and 1.69 kg/month for those without improvement. Improvement of
dysphagia
also affected favorably the psychological state of the patients. There were fewer cases of patient distrust of staff and less
despair
in those patients with improved
dysphagia
. Radiotherapy appears to contribute to better QOL in patients with inoperable esophageal cancer.
...
PMID:[QOL after radiotherapy for esophageal cancer]. 879 47
Oropharyngeal dysphagia describes difficulty with eating and drinking. This benign statement does not reflect the personal, social, and economic costs of the condition.
Dysphagia
has an insidious nature in that it cannot be 'seen' like a hemiplegia or a broken limb. It is often a comorbid condition, most notably of stroke, and many other neurodegenerative disorders. Conservative estimates of annual hospital costs associated with
dysphagia
run to USD 547 million. Length of stay rises by 1.64 days. The true prevalence of
dysphagia
is difficult to determine as it has been reported as a function of care setting, disease state and country of investigation. However, extrapolating from the literature, prevalence rises with admission to hospital and affects 55% of those in aged care settings. Consequences of
dysphagia
include malnutrition, dehydration, aspiration pneumonia and potentially death. The mean cost for an aspiration pneumonia episode of care is USD 17,000, rising with the number of comorbid conditions. Whilst financial costs can be objectively counted, the
despair
, depression, and social isolation are more difficult to quantify. Both sufferers and their families bear the social and psychological burden of
dysphagia
. There may be a cost-effective role for screening and early identification of
dysphagia
, particularly in high-risk populations.
...
PMID:Definition, prevalence and burden of oropharyngeal dysphagia: a serious problem among older adults worldwide and the impact on prognosis and hospital resources. 2305 95